Show simple item record

dc.contributor.authorHuerga, H
dc.contributor.authorBastard, M
dc.contributor.authorKamene, M
dc.contributor.authorWanjala, S
dc.contributor.authorArnold, A
dc.contributor.authorOucho, N
dc.contributor.authorChikwanha, I
dc.contributor.authorVaraine, F
dc.date.accessioned2017-02-28T21:37:19Z
dc.date.available2017-02-28T21:37:19Z
dc.date.issued2017-03-01
dc.date.submitted2017-02-27
dc.identifier.citationOutcomes From the First Multidrug-Resistant Tuberculosis Programme in Kenya. 2017, 21 (3):314-319 Int. J. Tuberc. Lung Dis.en
dc.identifier.issn1815-7920
dc.identifier.pmid28225342
dc.identifier.doi10.5588/ijtld.16.0661
dc.identifier.urihttp://hdl.handle.net/10144/618816
dc.descriptionAbstract available only. Full article is not open access. To access this article see additional links.en
dc.description.abstractIn March 2006, the first multidrug-resistant tuberculosis (MDR-TB) treatment programme was implemented in Kenya.
dc.language.isoenen
dc.publisherInternational Union Against Tuberculosis and Lung Diseaseen
dc.relation.urlhttps://www.ncbi.nlm.nih.gov/pubmed/28225342en
dc.rightsArchived with thanks to The International Journal of Tuberculosis and Lung disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease.en
dc.titleOutcomes From the First Multidrug-Resistant Tuberculosis Programme in Kenyaen
dc.identifier.journalThe International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Diseaseen
html.description.abstractIn March 2006, the first multidrug-resistant tuberculosis (MDR-TB) treatment programme was implemented in Kenya.


This item appears in the following Collection(s)

Show simple item record